CII
ATHN

CR Intrinsic Investors’s Athenahealth, Inc. ATHN Stock Holding History

CR Intrinsic Investors’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-31,001
Closed -$4.97M – 208
2014
Q1 		$4.97M Sell
31,001
-20,000
-39% -$3.29M 0.19% 172
2013
Q4 		$6.86M Buy
+51,001
New +$6.55M 0.3% 122
2013
Q3 		– Sell
-130,000
Closed -$11M – 434
2013
Q2 		$11M Buy
+130,000
New +$11.6M 0.38% 100

Other funds holding ATHN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

CR Intrinsic Investors's ATHN Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Athenahealth, Inc. (ATHN) in Q2 2014, closing a stake of 31,001 shares — an estimated $4.97M sold.

CR Intrinsic Investors first reported a position in ATHN in Q2 2013 and held it in 3 quarters. The position peaked at $11M in Q2 2013. 231 funds tracked by Wall St. Rank hold ATHN as of Q2 2014.

  • CR Intrinsic Investors reported no remaining Athenahealth, Inc. position as of Q2 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 31,001 Athenahealth, Inc. shares in Q2 2014, an estimated $4.97M.
  • CR Intrinsic Investors first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 3 quarters.
  • CR Intrinsic Investors's Athenahealth, Inc. position peaked at $11M in Q2 2013.
  • 231 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.